Table 2.
Clinical characteristics between patients with a positive and negative Strongyloides serology. NS: non-significant difference taken as p-value > 0.05.
| Strongyloides Negative (n = 388) | Strongyloides Positive (n = 115) | p-Value | |
|---|---|---|---|
| Characteristics | |||
| Male sex | 163 (42.3%) | 62 (53.9%) | 0.03 |
| Median age (IQR) | 48 (37–61) | 49 (42–59) | NS |
| Median eosinophil count (IQR) | 0.4 (0.2–0.5) | 0.5 (0.3–0.7) | <0.001 |
| Median number of years in the UK (IQR) | 24 (14–32) | 26 (15–37) | NS |
| Bangladesh heritage | 344 (88.7%) | 102 (88.7%) | NS |
| No work days missed | 294 (75.8%) | 90 (78.3%) | NS |
| Underlying immunosuppression | 1 (0.3%) | 1 (0.9%) | NS |
| Median impact on quality of life score | 0 (0–37) | 0 (0–54) | NS |
| Median IBS Score | 76 (0–200) | 70 (0–181) | NS |
| Symptoms | |||
| Abdominal Pain | 184 (47.4%) | 46 (40.0%) | |
| Distension | 145 (37.4%) | 53 (46.1%) | |
| Vomiting | 36 (9.3%) | 9 (7.8%) | |
| Indigestion | 172 (44.3%) | 48 (41.7%) | |
| Diarrhoea | 82 (21.1%) | 19 (16.5%) | |
| Constipation | 171 (44.1%) | 51 (44.4%) | |
| Flatulence | 162 (41.8%) | 38 (33.0%) | |